The U.S. Food and Drug Administration in 2010 issued a Plavix warning label to reflect that information. Bristol Myers and Sanofi faced a similar lawsuit from New Mexico, which settled in 2022.

Bristol-Myers Squibb Co. and Sanofi were ordered to pay the state of Hawaii more than $834 million for illegally marketing their blockbuster blood-thinning drug Plavix in a manner that put some ...

Sanofi-Aventis and Bristol-Myers Squibb Co. said they had settled a dispute with generic drug maker Apotex Inc. that could keep patent protection on their multibillion-dollar blood thinner Plavix ...

French drug maker Sanofi-Aventis SA warned that generic copies of the blood-thinner Plavix already on the market would undermine 2006 profit, as investors criticized Sanofi and partner Bristol ...

PARIS, Jan 18 (Reuters) - The odds on Sanofi-Aventis saving its patent on blockbuster Plavix from generic rivalry in the United States have improved, freeing the French drugmaker's hand for ...

This time, the state court ruled in favor of Hawaii's allegation that the companies violated state consumer protection laws with their marketing of Plavix. In 2010, the FDA required Sanofi and BMS ...

Bristol-Myers Squibb Co. and Sanofi were ordered to pay the state of Hawaii more than $834 million for illegally marketing their blockbuster blood-thinning drug Plavix in a manner that put some users’ ...

Bristol-Myers Squibb Co. and Sanofi were ordered to pay the state of Hawaii more than $834 million for illegally marketing their blockbuster blood-thinning drug Plavix in a manner that put some ...